v3.20.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 14,448,903 $ 1,516,272
Accounts receivable, net 962,983 1,710,665
Prepaid expenses and other current assets 527,059 519,063
Inventories, net 2,229,760 1,620,509
Advances on contracts 723,084 710,662
Total current assets 18,891,789 6,077,171
Furniture, fixtures and equipment, net 31,311 44,976
Patents, net 342,501 382,260
Right of use assets 655,870 15,977
Other assets 24,150 35,905
Total assets 19,945,621 6,556,289
Current liabilities:    
Accounts payable 666,094 1,379,425
Accounts payable, related party 393,090 1,358,752
Accrued expenses and other payables 1,147,698 775,055
Accrued expenses, related party 593,625 1,057,958
Current portion of finance leases 7,903 3,904
Current operating lease right-of-use liabilities 68,934 12,072
Note payable 276,180
Deferred profit, related party 340,476 340,476
Total current liabilities 3,494,000 4,927,642
Finance lease liabilities, non-current 30,624
Operating lease right-of-use liabilities 576,407
Total liabilities 4,101,031 4,927,642
Commitments and contingencies
Stockholders’ equity    
Common stock, par value $.001; authorized 75,000,000 shares; 63,605,119 shares issued and 63,571,786 shares outstanding as of September 30, 2020; 49,410,176 shares issued and 49,376,843 shares outstanding as of December 31, 2019; 63,605 49,410
Additional paid in capital 116,577,241 96,082,324
Accumulated deficit (99,806,352) (93,524,297)
Treasury stock, at cost, 33,333 shares (911,516) (911,516)
Total Milestone Scientific Inc. stockholders' equity 15,922,978 1,695,921
Noncontrolling interest (78,388) (67,274)
Total stockholders’ equity 15,844,590 1,628,647
Total liabilities and stockholders’ equity $ 19,945,621 $ 6,556,289

Source